Swiss National Bank
BVS icon

Swiss National Bank’s Bioventus BVS Stock Holding History

Swiss National Bank’s Portfolio BVS Stock Details BVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-70,500
Closed -$467K – 2326
2025
Q2 		$467K Hold
70,500
– – ﹤0.01% 2314
2025
Q1 		$645K Hold
70,500
– – ﹤0.01% 2293
2024
Q4 		$740K Buy
+70,500
New +$834K ﹤0.01% 2326
2023
Q1 		– Sell
-71,400
Closed -$186K – 2646
2022
Q4 		$186K Hold
71,400
– – ﹤0.01% 2671
2022
Q3 		$500K Hold
71,400
– – ﹤0.01% 2569
2022
Q2 		$487K Buy
+71,400
New +$729K ﹤0.01% 2612

Other funds holding BVS

EWM
Essex Woodlands Management The Woodlands, Texas $251M AUM 13.72% 1-Year Est. Return
JIC
Juniper Investment Company New York $313M AUM 79.58% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
KLP
Kent Lake PR Anasco, Puerto Rico $198M AUM 5.21% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Swiss National Bank's BVS Position: Q3 2025 in Review

Swiss National Bank sold out of Bioventus (BVS) in Q3 2025, closing a stake of 70,500 shares — an estimated $467K sold.

Swiss National Bank first reported a position in BVS in Q2 2022 and held it in 6 quarters. The position peaked at $740K in Q4 2024. 135 funds tracked by Wall St. Rank hold BVS as of Q3 2025.

  • Swiss National Bank reported no remaining Bioventus position as of Q3 2025 after selling out during the quarter.
  • Swiss National Bank sold 70,500 Bioventus shares in Q3 2025, an estimated $467K.
  • Swiss National Bank first reported a position in Bioventus in Q2 2022 and held it in 6 quarters.
  • Swiss National Bank's Bioventus position peaked at $740K in Q4 2024.
  • 135 funds tracked by Wall St. Rank held Bioventus as of Q3 2025.

Based on Swiss National Bank's 13F filing for Q3 2025, filed 13 Nov 2025.